Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
09/2001
09/13/2001US20010021715 Gastrointestinal disorders
09/13/2001CA2402174A1 Indole derivatives, process for preparation of the same and use thereof
09/13/2001CA2401524A1 New ccr5 modulators: benzimidazoles or benzotriazoles
09/12/2001EP1132379A1 Novel thiol derivatives, process for producing the same and utilization thereof
09/12/2001EP1131318A1 Process for making 5-substituted pyrazoles using dithietanes
09/12/2001EP1131297A1 Certain substituted caprolactams, pharmaceutical compositions containing them and their use in treating tumors
09/12/2001EP1131291A1 4-aroyl-piperidin-ccr-3 receptor antagonists iii
09/12/2001EP1131288A1 Pyrrolidine derivatives-ccr-3 receptor antagonists
09/12/2001EP0863141B1 Substituted heteroaromatic derivatives
09/12/2001EP0832066B1 Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors
09/12/2001CN1312807A Inhibitors of glycogen synthase kinase 3
09/12/2001CN1312806A Prodrugs of proton pump inhibitors
09/12/2001CN1312805A Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
09/12/2001CN1312803A Novel benzopykan or thiobenzopyran derivatives
09/12/2001CN1312799A Bispiperidines as antithrombotic agents
09/12/2001CN1312248A Pyrazole derivatives
09/12/2001CN1070701C Pyrimidine ortriazine carboxylic acid derivatives to be used as medicaments
09/11/2001US6288231 Peptide-containing α-ketoamide cysteine and serine protease inhibitors
09/11/2001US6288228 Triazine angiogenesis inhibitors
09/11/2001US6288120 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
09/11/2001US6288105 Antithrombotic agents
09/11/2001US6288103 Monocyte chemoattractant proteins antagonist such as n-(3-chlorophenylsulphonyl)indole-2-carboxylic acid; antiinflammatory agents
09/11/2001US6288086 N-hydroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
09/11/2001US6288085 Piperidine derivatives for treating psychoses
09/11/2001US6288084 Administering comounds such as 4-(4-chlorophenyl)-1-(4-(3-methoxyphenyl)-4-(3-pyridinyl)-3 -butenyl)piperidin-4-ol to treat diseases associated with aberrant leukocyte recruitment and/or activation
09/11/2001US6288083 Chemokine receptor antagonists and methods of use therefor
09/11/2001US6288068 Administering 1,4-disubstited piperidine derivative; alzheimer*s disease, cognition activators; anticholinergic agents
09/11/2001CA2031570C Substituted cyclohexenes as central nervous system agents
09/07/2001WO2001064676A2 INHIBITORS OF p38-α KINASE
09/07/2001WO2001064673A1 Flavone derivatives, preparation method and use as medicines
09/07/2001WO2001064670A1 Novel cyclic amide derivatives
09/07/2001WO2001064655A1 2, 4-di(hetero-)arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents
09/07/2001WO2001064652A1 Substituted 5-methyldihydropyridazinones and their use in the prophylaxis and/or treatment of anemias
09/07/2001WO2001064646A2 Hydrazones and analogs as cholesterol lowering agents
09/07/2001WO2001064643A2 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
09/07/2001WO2001064642A2 Benzamides and related inhibitors of factor xa
09/07/2001WO2001064640A1 2,3-dihydro-1h-indolinyl-alkanoic acids as cell adhesion inhibitors
09/07/2001WO2001064637A1 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
09/07/2001WO2001064633A1 Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
09/07/2001WO2001064632A1 Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
09/07/2001WO2001064216A1 4-alkyl piperidinyl pyrrolidine modulators of chemokine receptor activity
09/07/2001WO2001055111A8 Biaryl compounds, their preparation and their use in therapy
09/07/2001WO2001010863A3 Substituted thienyl(amino)sulfonylureas
09/07/2001WO2000062765A3 ESTROGEN RECEPTOR-β LIGANDS
09/07/2001CA2400138A1 Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
09/07/2001CA2400116A1 Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
09/07/2001CA2398685A1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents
09/06/2001US20010020035 Certain fused pyrrolecarboxamides a new class of gaba brain receptor
09/06/2001US20010020024 Opioid analgesics
09/06/2001US20010020021 Metalloprotease inhibitor
09/06/2001DE10010429A1 New 6-(4-sulfonamido-phenyl)-5-methyl-dihydropyridazinones, having erythropoietin sensitizing and erythropoiesis stimulating activity, useful for treating anemia
09/06/2001DE10010426A1 Medicaments, especially for treating anemia, containing 6-(4-(acylamino)-phenyl)-dihydropyridazinones having erythropoietin sensitizing and erythropoiesis stimulating activity
09/06/2001DE10010425A1 Medicaments for treating anemia, containing new or known 6-(4-(acylamino)-phenyl)-5-methyl-dihydropyridazinones having erythropoietin sensitizing and erythropoiesis stimulating activity
09/06/2001DE10010422A1 New 6-(4-carboxy-phenyl)-dihydropyridazinone esters or amides, having erythropoietin sensitizing and erythropoiesis stimulating activity, useful for treating anemia
09/05/2001EP1130017A2 Azole derivatives and their use as superoxide radical inhibitors
09/05/2001EP1130015A1 Pyridazinone derivatives
09/05/2001EP1129075A1 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as vegf receptor tyrosine kinase inhibitors
09/05/2001EP1129074A2 Antrhranilic acid amides and the use thereof as medicaments
09/05/2001EP1129071A1 Phenyl-substituted cyclic enaminones
09/05/2001EP0574510B1 2,4-diaryl-1,3-dithiolanes as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors
09/05/2001CN1311777A High affinity ligands for nociceptin receptor ORL-1
09/05/2001CN1311774A trifuoro methylpyrrol carboxamides
09/05/2001CN1311679A Benzimidazole derivatives as modulators of IgE
09/05/2001CN1311676A Compound that inhibit the binding of integrins to their receptors
09/05/2001CN1311675A Compounds having IgE affecting properties
09/05/2001CN1070488C Substituted arylalkylthioalkylthiopyridines for use in the control of helicobacter bacteria
09/04/2001US6284795 Sulfonamide compounds and methods of treating atherosclerosis and restenosis
09/04/2001US6284785 1-arenesulfonyl-2-aryl-pyrrolidine and pyridine derivatives
09/04/2001US6284774 4-Benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective NMDA receptor antagonists
09/04/2001US6284768 Src family SH2 domain inhibitors
09/04/2001US6284767 Retroviral protease inhibiting compounds
09/04/2001US6284756 Anticoagulant
09/04/2001US6284710 Substituting 2-amino-4-alkylamino-1,3,5-triazine as herbicide
09/04/2001CA2224062C Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors
08/2001
08/30/2001WO2001062765A2 Small molecule modulators of g protein-coupled receptor six
08/30/2001WO2001062756A1 Pyridinylimidazoles
08/30/2001WO2001062726A2 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
08/30/2001WO2001062715A1 Novel cd23 inhibitors
08/30/2001WO2001062233A2 Adenosine receptor modulators
08/30/2001WO2001016131A3 Five membered-ring compounds and utilization thereof in liquid crystal mixtures
08/30/2001WO2000075119A3 Substituted 2-aryl-1,2,4-triazine-3,5-di(thi)ones used as herbicides
08/30/2001WO2000073269A3 Nicotine receptor ligands
08/30/2001US20010018524 Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
08/30/2001US20010018523 Sulfonamide compounds and methods of treating atherosclerosis and restenosis
08/30/2001US20010018522 Neuropeptide y receptor ligand
08/30/2001US20010018449 Hypotensive agent, endothelial damage, arteriosclerosis, antidiabetic agents
08/30/2001US20010018443 Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds
08/30/2001US20010018438 Nervous system disorders; psychological disorders
08/30/2001DE10009000A1 Verfahren zur Herstellung substituierter Indole A process for the preparation of substituted indoles
08/30/2001CA2401036A1 Pyridinylimidazoles
08/30/2001CA2368447A1 Small molecule modulators of g protein-coupled receptor six
08/29/2001EP1127880A2 Phenylacetic acid derivatives substituted by a heterocycle and their use as A-II antagonists and as inhibitors of smooth muscle cell proliferation
08/29/2001EP1127874A2 Process for the preparation of substituted indoles
08/29/2001EP1127051A2 Tricyclic pyrazole derivatives
08/29/2001CN1310717A Process for the dehalogenation of thiochroman and dihydrobenzothiophene derivatives
08/29/2001CN1310706A Inhibitors of phospholipase enzymes
08/29/2001CN1310705A Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation
08/29/2001CN1310702A Nitric ester and nitrate salts of specific drugs
08/29/2001CN1310619A Use of glucose uptake enhancer for reducing post-ischemic injury of the heart
08/29/2001CN1070192C Thiopyridine for use in control of helicobacter bacteria